Research Repository

Items where Author is "Brooke, GN"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 16.

Article

Leach, DA and Mohr, A and Giotis, ES and Cil, E and Isac, AM and Yates, LL and Barclay, WS and Zwacka, RM and Bevan, CL and Brooke, GN (2021) 'The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells.' Nature Communications, 12 (1). ISSN 2041-1723

Pine, AC and Fioretti, FF and Brooke, GN and Bevan, CL (2016) 'Advances in genetics: Widening our understanding of prostate cancer [version 1; referees: 2 approved].' F1000Research, 5. ISSN 2046-1402

Brooke, GN and Gamble, SC and Hough, MA and Begum, S and Dart, DA and Odontiadis, M and Powell, SM and Fioretti, FM and Bryan, RA and Waxman, J and Wait, R and Bevan, CL (2015) 'Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells.' Molecular and Cellular Proteomics, 14 (5). 1201 - 1216. ISSN 1535-9476

Querol Cano, L and Lavery, DN and Sin, S and Spanjaard, E and Brooke, GN and Tilman, JD and Abroaf, A and Gaughan, L and Robson, CN and Heer, R and Mauri, F and de Rooij, J and Driouch, K and Bevan, CL (2015) 'The co-chaperone p23 promotes prostate cancer motility and metastasis.' Molecular Oncology, 9 (1). 295 - 308. ISSN 1574-7891

Rudraraju, B and Droog, M and Abdel-Fatah, TMA and Zwart, W and Giannoudis, A and Malki, MI and Moore, D and Patel, H and Shaw, J and Ellis, IO and Chan, S and Brooke, GN and Nevedomskaya, E and Nigro, CL and Carroll, J and Coombes, RC and Bevan, C and Ali, S and Palmieri, C (2014) 'Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer.' Breast Cancer Research and Treatment, 147 (2). 295 - 309. ISSN 0167-6806

Fioretti, FM and Sita-Lumsden, A and Bevan, CL and Brooke, GN (2014) 'Revising the role of the androgen receptor in breast cancer.' Journal of Molecular Endocrinology, 52 (3). ISSN 0952-5041

Brooke, GN and Powell, SM and Lavery, DN and Waxman, J and Buluwela, L and Ali, S and Bevan, CL (2014) 'Engineered repressors are potent inhibitors of androgen receptor activity.' Oncotarget, 5 (4). 959 - 969. ISSN 1949-2553

Sita-Lumsden, A and Fletcher, CE and Dart, DA and Brooke, GN and Waxman, J and Bevan, CL (2013) 'Circulating nucleic acids as biomarkers of prostate cancer.' Biomarkers in Medicine, 7 (6). 867 - 877. ISSN 1752-0363

Ottaviani, S and Brooke, GN and O'Hanlon-Brown, C and Waxman, J and Ali, S and Buluwela, L (2013) 'Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells.' Journal of Molecular Endocrinology, 51 (3). 301 - 312. ISSN 0952-5041

Dart, DA and Brooke, GN and Sita-Lumsden, A and Waxman, J and Bevan, CL (2012) 'Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens.' Oncogene, 31 (43). 4588 - 4598. ISSN 0950-9232

Reebye, V and Cano, LQ and Lavery, DN and Brooke, GN and Powell, SM and Chotai, D and Walker, MM and Whitaker, HC and Wait, R and Hurst, HC and Bevan, CL (2012) 'Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancer.' Molecular Endocrinology, 26 (10). 1694 - 1706. ISSN 0888-8809

Brooke, GN and Culley, RL and Dart, DA and Mann, DJ and Gaughan, L and McCracken, SR and Robson, CN and Spencer-Dene, B and Gamble, SC and Powell, SM and Wait, R and Waxman, J and Walker, MM and Bevan, CL (2011) 'FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth.' Cancer Research, 71 (3). 914 - 924. ISSN 0008-5472

Brooke, GN and Bevan, CL (2009) 'The role of androgen receptor mutations in prostate cancer progression.' Current Genomics, 10 (1). 18 - 25. ISSN 1389-2029

Brooke, GN and Parker, MG and Bevan, CL (2008) 'Mechanisms of androgen receptor activation in advanced prostate cancer: Differential co-activator recruitment and gene expression.' Oncogene, 27 (21). 2941 - 2950. ISSN 0950-9232

Gamble, SC and Chotai, D and Odontiadis, M and Dart, DA and Brooke, GN and Powell, SM and Reebye, V and Varela-Carver, A and Kawano, Y and Waxman, J and Bevan, CL (2007) 'Prohibitin, a protein downregulated by androgens, represses androgen receptor activity.' Oncogene, 26 (12). 1757 - 1768. ISSN 0950-9232

Powell, SM and Brooke, GN and Whitaker, HC and Reebye, V and Gamble, SC and Chotai, D and Dart, DA and Belandia, B and Bevan, CL (2006) 'Mechanisms of androgen receptor repression in prostate cancer.' Biochemical Society Transactions, 34 (6). 1124 - 1127. ISSN 0300-5127

This list was generated on Wed Sep 22 15:13:35 2021 BST.